世界の同種異系ヒト軟骨細胞市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Allogeneic Human Chondrocyte Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3780
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、同種異系ヒト軟骨細胞の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（病院、専門クリニック、外来外科センター）、用途別市場規模（変形性関節症、筋骨格系障害、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・同種異系ヒト軟骨細胞の市場動向
・企業の競争状況、市場シェア
・同種異系ヒト軟骨細胞の種類別市場規模と予測2016-2027（病院、専門クリニック、外来外科センター）
・同種異系ヒト軟骨細胞の用途別市場規模と予測2016-2027（変形性関節症、筋骨格系障害、その他）
・同種異系ヒト軟骨細胞の北米市場規模2016-2027（アメリカ、カナダ）
・同種異系ヒト軟骨細胞の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・同種異系ヒト軟骨細胞のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・同種異系ヒト軟骨細胞の中南米市場規模2016-2027（メキシコ、ブラジル）
・同種異系ヒト軟骨細胞の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Kolon TissueGene, Inc.、ISTO Technologies Inc.、Zimmer Biomet、Genzyme、CellGenix、EMD Serono）
・結論

Allogeneic human chondrocyte is an emerging therapy that can be used for cartilage repair and other indications. Only few players are involved in the development of this treatment procedure. Allogeneic human articular chondrocytes (hAC) could be a good alternative; however, the possibility of immunological incompatibility between recipient and hAC donor should be considered.

Market Analysis and Insights: Global Allogeneic Human Chondrocyte Market
The global Allogeneic Human Chondrocyte market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Allogeneic Human Chondrocyte market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Allogeneic Human Chondrocyte market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Allogeneic Human Chondrocyte market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Allogeneic Human Chondrocyte market.

Global Allogeneic Human Chondrocyte Scope and Market Size
Allogeneic Human Chondrocyte market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Allogeneic Human Chondrocyte market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Hospitals
Specialty Clinics
Ambulatory Surgical Centers

Segment by Application
Osteoarthritis
Musculoskeletal System Disorders
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Kolon TissueGene, Inc.
ISTO Technologies Inc.
Zimmer Biomet
Genzyme
CellGenix
EMD Serono

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Allogeneic Human Chondrocyte Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Hospitals
1.2.3 Specialty Clinics
1.2.4 Ambulatory Surgical Centers
1.3 Market by Application
1.3.1 Global Allogeneic Human Chondrocyte Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Osteoarthritis
1.3.3 Musculoskeletal System Disorders
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Allogeneic Human Chondrocyte Market Perspective (2016-2027)
2.2 Allogeneic Human Chondrocyte Growth Trends by Regions
2.2.1 Allogeneic Human Chondrocyte Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Allogeneic Human Chondrocyte Historic Market Share by Regions (2016-2021)
2.2.3 Allogeneic Human Chondrocyte Forecasted Market Size by Regions (2022-2027)
2.3 Allogeneic Human Chondrocyte Industry Dynamic
2.3.1 Allogeneic Human Chondrocyte Market Trends
2.3.2 Allogeneic Human Chondrocyte Market Drivers
2.3.3 Allogeneic Human Chondrocyte Market Challenges
2.3.4 Allogeneic Human Chondrocyte Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Allogeneic Human Chondrocyte Players by Revenue
3.1.1 Global Top Allogeneic Human Chondrocyte Players by Revenue (2016-2021)
3.1.2 Global Allogeneic Human Chondrocyte Revenue Market Share by Players (2016-2021)
3.2 Global Allogeneic Human Chondrocyte Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Allogeneic Human Chondrocyte Revenue
3.4 Global Allogeneic Human Chondrocyte Market Concentration Ratio
3.4.1 Global Allogeneic Human Chondrocyte Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Allogeneic Human Chondrocyte Revenue in 2020
3.5 Allogeneic Human Chondrocyte Key Players Head office and Area Served
3.6 Key Players Allogeneic Human Chondrocyte Product Solution and Service
3.7 Date of Enter into Allogeneic Human Chondrocyte Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Allogeneic Human Chondrocyte Breakdown Data by Type
4.1 Global Allogeneic Human Chondrocyte Historic Market Size by Type (2016-2021)
4.2 Global Allogeneic Human Chondrocyte Forecasted Market Size by Type (2022-2027)

5 Allogeneic Human Chondrocyte Breakdown Data by Application
5.1 Global Allogeneic Human Chondrocyte Historic Market Size by Application (2016-2021)
5.2 Global Allogeneic Human Chondrocyte Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Allogeneic Human Chondrocyte Market Size (2016-2027)
6.2 North America Allogeneic Human Chondrocyte Market Size by Type
6.2.1 North America Allogeneic Human Chondrocyte Market Size by Type (2016-2021)
6.2.2 North America Allogeneic Human Chondrocyte Market Size by Type (2022-2027)
6.2.3 North America Allogeneic Human Chondrocyte Market Size by Type (2016-2027)
6.3 North America Allogeneic Human Chondrocyte Market Size by Application
6.3.1 North America Allogeneic Human Chondrocyte Market Size by Application (2016-2021)
6.3.2 North America Allogeneic Human Chondrocyte Market Size by Application (2022-2027)
6.3.3 North America Allogeneic Human Chondrocyte Market Size by Application (2016-2027)
6.4 North America Allogeneic Human Chondrocyte Market Size by Country
6.4.1 North America Allogeneic Human Chondrocyte Market Size by Country (2016-2021)
6.4.2 North America Allogeneic Human Chondrocyte Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Allogeneic Human Chondrocyte Market Size (2016-2027)
7.2 Europe Allogeneic Human Chondrocyte Market Size by Type
7.2.1 Europe Allogeneic Human Chondrocyte Market Size by Type (2016-2021)
7.2.2 Europe Allogeneic Human Chondrocyte Market Size by Type (2022-2027)
7.2.3 Europe Allogeneic Human Chondrocyte Market Size by Type (2016-2027)
7.3 Europe Allogeneic Human Chondrocyte Market Size by Application
7.3.1 Europe Allogeneic Human Chondrocyte Market Size by Application (2016-2021)
7.3.2 Europe Allogeneic Human Chondrocyte Market Size by Application (2022-2027)
7.3.3 Europe Allogeneic Human Chondrocyte Market Size by Application (2016-2027)
7.4 Europe Allogeneic Human Chondrocyte Market Size by Country
7.4.1 Europe Allogeneic Human Chondrocyte Market Size by Country (2016-2021)
7.4.2 Europe Allogeneic Human Chondrocyte Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Allogeneic Human Chondrocyte Market Size (2016-2027)
8.2 Asia-Pacific Allogeneic Human Chondrocyte Market Size by Type
8.2.1 Asia-Pacific Allogeneic Human Chondrocyte Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Allogeneic Human Chondrocyte Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Allogeneic Human Chondrocyte Market Size by Type (2016-2027)
8.3 Asia-Pacific Allogeneic Human Chondrocyte Market Size by Application
8.3.1 Asia-Pacific Allogeneic Human Chondrocyte Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Allogeneic Human Chondrocyte Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Allogeneic Human Chondrocyte Market Size by Application (2016-2027)
8.4 Asia-Pacific Allogeneic Human Chondrocyte Market Size by Region
8.4.1 Asia-Pacific Allogeneic Human Chondrocyte Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Allogeneic Human Chondrocyte Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Allogeneic Human Chondrocyte Market Size (2016-2027)
9.2 Latin America Allogeneic Human Chondrocyte Market Size by Type
9.2.1 Latin America Allogeneic Human Chondrocyte Market Size by Type (2016-2021)
9.2.2 Latin America Allogeneic Human Chondrocyte Market Size by Type (2022-2027)
9.2.3 Latin America Allogeneic Human Chondrocyte Market Size by Type (2016-2027)
9.3 Latin America Allogeneic Human Chondrocyte Market Size by Application
9.3.1 Latin America Allogeneic Human Chondrocyte Market Size by Application (2016-2021)
9.3.2 Latin America Allogeneic Human Chondrocyte Market Size by Application (2022-2027)
9.3.3 Latin America Allogeneic Human Chondrocyte Market Size by Application (2016-2027)
9.4 Latin America Allogeneic Human Chondrocyte Market Size by Country
9.4.1 Latin America Allogeneic Human Chondrocyte Market Size by Country (2016-2021)
9.4.2 Latin America Allogeneic Human Chondrocyte Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Allogeneic Human Chondrocyte Market Size (2016-2027)
10.2 Middle East & Africa Allogeneic Human Chondrocyte Market Size by Type
10.2.1 Middle East & Africa Allogeneic Human Chondrocyte Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Allogeneic Human Chondrocyte Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Allogeneic Human Chondrocyte Market Size by Type (2016-2027)
10.3 Middle East & Africa Allogeneic Human Chondrocyte Market Size by Application
10.3.1 Middle East & Africa Allogeneic Human Chondrocyte Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Allogeneic Human Chondrocyte Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Allogeneic Human Chondrocyte Market Size by Application (2016-2027)
10.4 Middle East & Africa Allogeneic Human Chondrocyte Market Size by Country
10.4.1 Middle East & Africa Allogeneic Human Chondrocyte Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Allogeneic Human Chondrocyte Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Kolon TissueGene, Inc.
11.1.1 Kolon TissueGene, Inc. Company Details
11.1.2 Kolon TissueGene, Inc. Business Overview
11.1.3 Kolon TissueGene, Inc. Allogeneic Human Chondrocyte Introduction
11.1.4 Kolon TissueGene, Inc. Revenue in Allogeneic Human Chondrocyte Business (2016-2021)
11.1.5 Kolon TissueGene, Inc. Recent Development
11.2 ISTO Technologies Inc.
11.2.1 ISTO Technologies Inc. Company Details
11.2.2 ISTO Technologies Inc. Business Overview
11.2.3 ISTO Technologies Inc. Allogeneic Human Chondrocyte Introduction
11.2.4 ISTO Technologies Inc. Revenue in Allogeneic Human Chondrocyte Business (2016-2021)
11.2.5 ISTO Technologies Inc. Recent Development
11.3 Zimmer Biomet
11.3.1 Zimmer Biomet Company Details
11.3.2 Zimmer Biomet Business Overview
11.3.3 Zimmer Biomet Allogeneic Human Chondrocyte Introduction
11.3.4 Zimmer Biomet Revenue in Allogeneic Human Chondrocyte Business (2016-2021)
11.3.5 Zimmer Biomet Recent Development
11.4 Genzyme
11.4.1 Genzyme Company Details
11.4.2 Genzyme Business Overview
11.4.3 Genzyme Allogeneic Human Chondrocyte Introduction
11.4.4 Genzyme Revenue in Allogeneic Human Chondrocyte Business (2016-2021)
11.4.5 Genzyme Recent Development
11.5 CellGenix
11.5.1 CellGenix Company Details
11.5.2 CellGenix Business Overview
11.5.3 CellGenix Allogeneic Human Chondrocyte Introduction
11.5.4 CellGenix Revenue in Allogeneic Human Chondrocyte Business (2016-2021)
11.5.5 CellGenix Recent Development
11.6 EMD Serono
11.6.1 EMD Serono Company Details
11.6.2 EMD Serono Business Overview
11.6.3 EMD Serono Allogeneic Human Chondrocyte Introduction
11.6.4 EMD Serono Revenue in Allogeneic Human Chondrocyte Business (2016-2021)
11.6.5 EMD Serono Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Allogeneic Human Chondrocyte Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Hospitals
Table 3. Key Players of Specialty Clinics
Table 4. Key Players of Ambulatory Surgical Centers
Table 5. Global Allogeneic Human Chondrocyte Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Allogeneic Human Chondrocyte Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Allogeneic Human Chondrocyte Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Allogeneic Human Chondrocyte Market Share by Regions (2016-2021)
Table 9. Global Allogeneic Human Chondrocyte Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Allogeneic Human Chondrocyte Market Share by Regions (2022-2027)
Table 11. Allogeneic Human Chondrocyte Market Trends
Table 12. Allogeneic Human Chondrocyte Market Drivers
Table 13. Allogeneic Human Chondrocyte Market Challenges
Table 14. Allogeneic Human Chondrocyte Market Restraints
Table 15. Global Allogeneic Human Chondrocyte Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Allogeneic Human Chondrocyte Market Share by Players (2016-2021)
Table 17. Global Top Allogeneic Human Chondrocyte Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Allogeneic Human Chondrocyte as of 2020)
Table 18. Ranking of Global Top Allogeneic Human Chondrocyte Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Allogeneic Human Chondrocyte Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Allogeneic Human Chondrocyte Product Solution and Service
Table 22. Date of Enter into Allogeneic Human Chondrocyte Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Allogeneic Human Chondrocyte Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Allogeneic Human Chondrocyte Revenue Market Share by Type (2016-2021)
Table 26. Global Allogeneic Human Chondrocyte Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Allogeneic Human Chondrocyte Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Allogeneic Human Chondrocyte Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Allogeneic Human Chondrocyte Revenue Market Share by Application (2016-2021)
Table 30. Global Allogeneic Human Chondrocyte Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Allogeneic Human Chondrocyte Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Allogeneic Human Chondrocyte Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Allogeneic Human Chondrocyte Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Allogeneic Human Chondrocyte Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Allogeneic Human Chondrocyte Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Allogeneic Human Chondrocyte Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Allogeneic Human Chondrocyte Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Allogeneic Human Chondrocyte Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Allogeneic Human Chondrocyte Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Allogeneic Human Chondrocyte Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Allogeneic Human Chondrocyte Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Allogeneic Human Chondrocyte Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Allogeneic Human Chondrocyte Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Allogeneic Human Chondrocyte Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Allogeneic Human Chondrocyte Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Allogeneic Human Chondrocyte Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Allogeneic Human Chondrocyte Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Allogeneic Human Chondrocyte Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Allogeneic Human Chondrocyte Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Allogeneic Human Chondrocyte Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Allogeneic Human Chondrocyte Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Allogeneic Human Chondrocyte Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Allogeneic Human Chondrocyte Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Allogeneic Human Chondrocyte Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Allogeneic Human Chondrocyte Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Allogeneic Human Chondrocyte Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Allogeneic Human Chondrocyte Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Allogeneic Human Chondrocyte Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Allogeneic Human Chondrocyte Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Allogeneic Human Chondrocyte Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Allogeneic Human Chondrocyte Market Size by Country (2022-2027) & (US$ Million)
Table 62. Kolon TissueGene, Inc. Company Details
Table 63. Kolon TissueGene, Inc. Business Overview
Table 64. Kolon TissueGene, Inc. Allogeneic Human Chondrocyte Product
Table 65. Kolon TissueGene, Inc. Revenue in Allogeneic Human Chondrocyte Business (2016-2021) & (US$ Million)
Table 66. Kolon TissueGene, Inc. Recent Development
Table 67. ISTO Technologies Inc. Company Details
Table 68. ISTO Technologies Inc. Business Overview
Table 69. ISTO Technologies Inc. Allogeneic Human Chondrocyte Product
Table 70. ISTO Technologies Inc. Revenue in Allogeneic Human Chondrocyte Business (2016-2021) & (US$ Million)
Table 71. ISTO Technologies Inc. Recent Development
Table 72. Zimmer Biomet Company Details
Table 73. Zimmer Biomet Business Overview
Table 74. Zimmer Biomet Allogeneic Human Chondrocyte Product
Table 75. Zimmer Biomet Revenue in Allogeneic Human Chondrocyte Business (2016-2021) & (US$ Million)
Table 76. Zimmer Biomet Recent Development
Table 77. Genzyme Company Details
Table 78. Genzyme Business Overview
Table 79. Genzyme Allogeneic Human Chondrocyte Product
Table 80. Genzyme Revenue in Allogeneic Human Chondrocyte Business (2016-2021) & (US$ Million)
Table 81. Genzyme Recent Development
Table 82. CellGenix Company Details
Table 83. CellGenix Business Overview
Table 84. CellGenix Allogeneic Human Chondrocyte Product
Table 85. CellGenix Revenue in Allogeneic Human Chondrocyte Business (2016-2021) & (US$ Million)
Table 86. CellGenix Recent Development
Table 87. EMD Serono Company Details
Table 88. EMD Serono Business Overview
Table 89. EMD Serono Allogeneic Human Chondrocyte Product
Table 90. EMD Serono Revenue in Allogeneic Human Chondrocyte Business (2016-2021) & (US$ Million)
Table 91. EMD Serono Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Allogeneic Human Chondrocyte Market Share by Type: 2020 VS 2027
Figure 2. Hospitals Features
Figure 3. Specialty Clinics Features
Figure 4. Ambulatory Surgical Centers Features
Figure 5. Global Allogeneic Human Chondrocyte Market Share by Application: 2020 VS 2027
Figure 6. Osteoarthritis Case Studies
Figure 7. Musculoskeletal System Disorders Case Studies
Figure 8. Others Case Studies
Figure 9. Allogeneic Human Chondrocyte Report Years Considered
Figure 10. Global Allogeneic Human Chondrocyte Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Allogeneic Human Chondrocyte Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Allogeneic Human Chondrocyte Market Share by Regions: 2020 VS 2027
Figure 13. Global Allogeneic Human Chondrocyte Market Share by Regions (2022-2027)
Figure 14. Global Allogeneic Human Chondrocyte Market Share by Players in 2020
Figure 15. Global Top Allogeneic Human Chondrocyte Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Allogeneic Human Chondrocyte as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Allogeneic Human Chondrocyte Revenue in 2020
Figure 17. Global Allogeneic Human Chondrocyte Revenue Market Share by Type (2016-2021)
Figure 18. Global Allogeneic Human Chondrocyte Revenue Market Share by Type (2022-2027)
Figure 19. North America Allogeneic Human Chondrocyte Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Allogeneic Human Chondrocyte Market Share by Type (2016-2027)
Figure 21. North America Allogeneic Human Chondrocyte Market Share by Application (2016-2027)
Figure 22. North America Allogeneic Human Chondrocyte Market Share by Country (2016-2027)
Figure 23. United States Allogeneic Human Chondrocyte Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Allogeneic Human Chondrocyte Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Allogeneic Human Chondrocyte Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Allogeneic Human Chondrocyte Market Share by Type (2016-2027)
Figure 27. Europe Allogeneic Human Chondrocyte Market Share by Application (2016-2027)
Figure 28. Europe Allogeneic Human Chondrocyte Market Share by Country (2016-2027)
Figure 29. Germany Allogeneic Human Chondrocyte Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Allogeneic Human Chondrocyte Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Allogeneic Human Chondrocyte Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Allogeneic Human Chondrocyte Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Allogeneic Human Chondrocyte Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Allogeneic Human Chondrocyte Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Allogeneic Human Chondrocyte Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Allogeneic Human Chondrocyte Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Allogeneic Human Chondrocyte Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Allogeneic Human Chondrocyte Market Share by Region (2016-2027)
Figure 39. China Allogeneic Human Chondrocyte Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Allogeneic Human Chondrocyte Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Allogeneic Human Chondrocyte Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Allogeneic Human Chondrocyte Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Allogeneic Human Chondrocyte Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Allogeneic Human Chondrocyte Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Allogeneic Human Chondrocyte Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Allogeneic Human Chondrocyte Market Share by Type (2016-2027)
Figure 47. Latin America Allogeneic Human Chondrocyte Market Share by Application (2016-2027)
Figure 48. Latin America Allogeneic Human Chondrocyte Market Share by Country (2016-2027)
Figure 49. Mexico Allogeneic Human Chondrocyte Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Allogeneic Human Chondrocyte Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Allogeneic Human Chondrocyte Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Allogeneic Human Chondrocyte Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Allogeneic Human Chondrocyte Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Allogeneic Human Chondrocyte Market Share by Country (2016-2027)
Figure 55. Turkey Allogeneic Human Chondrocyte Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Allogeneic Human Chondrocyte Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Allogeneic Human Chondrocyte Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Kolon TissueGene, Inc. Revenue Growth Rate in Allogeneic Human Chondrocyte Business (2016-2021)
Figure 59. ISTO Technologies Inc. Revenue Growth Rate in Allogeneic Human Chondrocyte Business (2016-2021)
Figure 60. Zimmer Biomet Revenue Growth Rate in Allogeneic Human Chondrocyte Business (2016-2021)
Figure 61. Genzyme Revenue Growth Rate in Allogeneic Human Chondrocyte Business (2016-2021)
Figure 62. CellGenix Revenue Growth Rate in Allogeneic Human Chondrocyte Business (2016-2021)
Figure 63. EMD Serono Revenue Growth Rate in Allogeneic Human Chondrocyte Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

以下、関連資料のご紹介

世界の同種異系幹細胞治療市場規模・現状・予測（2021年-2027年）

Global Allogeneic Stem Cell Therapy Market Size, Status and Forecast 2021-2027
QFJ1-3781 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、同種異系幹細胞治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（成体幹細胞治療、ヒト胚性幹細胞治療、人工多能性幹細胞治療、その他）、用途別市場規模（筋骨格系障害、傷＆怪我、心血管疾患、その他）、主要...

世界のヒト遺伝学市場規模・現状・予測（2021年-2027年）

Global Human Genetics Market Size, Status and Forecast 2021-2027
QFJ1-4330 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、ヒト遺伝学の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（細胞遺伝学、出生前遺伝学、分子遺伝学、症状遺伝学）、用途別市場規模（研究センター、病院、法医学研究所）、主要地域別市場規模（北米、アメリカ、欧...

世界のヒトDNAワクチン市場規模・現状・予測（2021年-2027年）

Global Human DNA Vaccines Market Size, Status and Forecast 2021-2027
QFJ1-4329 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、ヒトDNAワクチンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（遺伝子組換えタンパク質ワクチン、遺伝子ワクチン）、用途別市場規模（インフルエンザ、ヒトパピローマウイルス、HIV）、主要地域別市場規模...

世界のヒトエリスロポエチン市場規模・現状・予測（2021年-2027年）

Global Human Erythropoietin Market Size, Status and Forecast 2021-2027
QFJ1-5785 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、ヒトエリスロポエチンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エポエチンアルファ、エポエチンベータ、ダルベポエチンアルファ、その他）、用途別市場規模（貧血、腎疾患、その他）、主要地域別市場規模（...

世界のヒトIoT市場規模・現状・予測（2021年-2027年）

Global Human Internet of Things Market Size, Status and Forecast 2021-2027
QFJ1-3102 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、ヒトIoTの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（デバイス管理、セマンティック標準、セキュリティ）、用途別市場規模（医療用、ロボット、バイオセンサー、スマートピル、その他）、主要地域別市場規模...

世界のヒト臍帯静脈内皮細胞 (HUVEC)市場規模・現状・予測（2021年-2027年）

Global Human Umbilical Vein Endothelial Cells (HUVEC) Market Size, Status and Forecast 2021-2027
QFJ1-5789 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、ヒト臍帯静脈内皮細胞 (HUVEC)の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（シングルドナー、プールドドナー）、用途別市場規模（癒やし、血管新生、組織工学、炎症、腫瘍学、その他）、主要地域別市場...

世界のヒトアクチビンA市場規模・現状・予測（2021年-2027年）

Global Human Activin A Market Size, Status and Forecast 2021-2027
QFJ1-5784 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、ヒトアクチビンAの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（純度99%以上、純度95%以上）、用途別市場規模（商業研究、学術研究）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界のヒト白血球抗原（HLA）検査市場規模・現状・予測（2021年-2027年）

Global Human Leukocyte Antigen (HLA) Testing Market Size, Status and Forecast 2021-2027
QFJ1-5200 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、ヒト白血球抗原（HLA）検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（分子計測技術、非分子計測技術）、用途別市場規模（病院、研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日...

世界の血漿由来人血清アルブミン検査市場規模・現状・予測（2021年-2027年）

Global Plasma-derived Human Serum Albumin Test Market Size, Status and Forecast 2021-2027
QFJ1-4717 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、血漿由来人血清アルブミン検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（機器、消耗品、その他）、用途別市場規模（病院・クリニック、診断研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の組換えヒトEGF市場規模・現状・予測（2021年-2027年）

Global Recombinant Human EGF Market Size, Status and Forecast 2021-2027
QFJ1-4797 2021年6月 127Pages
QYResearch社発行の本調査レポートでは、組換えヒトEGFの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（≥98％SDS-PAGE、95％-98％SDS-PAGE、<95％SDS-PAGE）、用途別市場規模（科学研究、医薬品、その他）、主要地...

世界の同種異系幹細胞治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Allogeneic Stem Cell Therapy Market The global Allogeneic Stem Cell Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integri…
世界のヒトエリスロポエチン市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Human Erythropoietin Market The global Human Erythropoietin market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report m…
世界のヒト遺伝学市場規模・現状・予測（2021年-2027年） Human genetics is the study of inheritance as it occurs in human beings. Genes can be the common factor of the qualities of most human-inherited traits. Market Analysis and Insights: Global Human Genetics Market The global Human Genetics market size is projected to reach US$ XX million by 2027, from…
世界のヒトIoT市場規模・現状・予測（2021年-2027年） Internet of things is a concept of connecting any device to the internet or any other connected devices. Market Analysis and Insights: Global Human Internet of Things Market The global Human Internet of Things market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at …
世界のヒトDNAワクチン市場規模・現状・予測（2021年-2027年） DNA vaccines have evolved greatly over the last 20 years since their invention, but have yet to become a competitive alternative to conventional protein or carbohydrate based human vaccines. Whilst safety concerns were an initial barrier, the Achilles heel of DNA vaccines remains their poor immunoge…